Solid Biosciences Inc.

SLDB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$125-$96-$86-$72
Dep. & Amort.$2$3$2$3
Deferred Tax$0$0$0$1
Stock-Based Comp.$11$8$8$13
Change in WC$3-$6-$4-$23
Other Non-Cash$9-$2-$18-$0
Operating Cash Flow-$100-$94-$98-$78
Investing Activities
PP&E Inv.-$1-$2-$3-$1
Net Acquisitions$0$0$32$90
Inv. Purchases-$204-$117-$183-$141
Inv. Sales/Matur.$189$129$213$51
Other Inv. Act.$0$0$1-$90
Investing Cash Flow-$16$10$59-$91
Financing Activities
Debt Repay.-$0$0$2$0
Stock Issued$127$3$73$135
Stock Repurch.-$5$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$0$0
Financing Cash Flow$122$3$75$135
Forex Effect$0$0$0$0
Net Chg. in Cash$6-$81$36-$34
Supplemental Information
Beg. Cash$76$155$121$155
End Cash$82$74$157$121
Free Cash Flow-$101-$96-$101-$79